Precision Biosciences (DTIL) Shareholder's Equity Growth (1y) (2019 - 2026)
Precision Biosciences (DTIL) Shareholder's Equity Growth (1y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Precision Biosciences |
168.99 Mn |
67.81 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
54.25% |
| Dec 31, 2025 |
63.58% |
| Sep 30, 2025 |
-74.36% |
| Jun 30, 2025 |
-54.42% |
| Mar 31, 2025 |
32.60% |
| Dec 31, 2024 |
198.99% |
| Sep 30, 2024 |
123.19% |
| Jun 30, 2024 |
119.48% |
| Mar 31, 2024 |
-7.39% |
| Dec 31, 2023 |
-68.79% |
| Sep 30, 2023 |
-65.56% |
| Jun 30, 2023 |
-66.96% |
| Mar 31, 2023 |
-42.32% |
| Dec 31, 2022 |
-33.71% |
| Sep 30, 2022 |
-16.82% |
| Jun 30, 2022 |
2.46% |
| Mar 31, 2022 |
18.42% |
| Dec 31, 2021 |
105.22% |
| Sep 30, 2021 |
58.94% |
| Jun 30, 2021 |
17.47% |
